Gout flareups may precede heart attack, stroke, study says
The risk of heart attack and stroke temporarily increases in the four months after a gout flare, a British study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 2, 2022 Category: Consumer Health News Source Type: news
Don't Use Luvox, Colchicine to Fight COVID, WHO Experts Say
FRIDAY, July 15, 2022 -- People shouldn ’t take the drugs colchicine and fluvoxamine to treat mild to moderate COVID-19, the World Health Organization (WHO) is warning.
The antidepressant drug fluvoxamine (Luvox) and the gout drug colchicine are... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 15, 2022 Category: General Medicine Source Type: news
WHO Experts Advise Against a Generic Antidepressant to Treat COVID-19
A generic antidepressant and a gout medicine that garnered some popularity as COVID-19 treatments shouldn’t be used for mild infection because there’s no evidence they help, according to a panel of experts advising the World Health Organization.
The drugs, fluvoxamine and colchicine, could potentially cause harm, the group of experts said in the BMJ medical journal Thursday. The panel didn’t give advice for severe illness, saying there was a lack of data.
The two medicines “are commonly used, inexpensive drugs that have received considerable interest as potential COVID-19 treatments during the pande...
Source: TIME: Health - July 14, 2022 Category: Consumer Health News Authors: Marthe Fourcade / AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news
Benzbromarone Tops Febuxostat for Gout? Benzbromarone Tops Febuxostat for Gout?
In countries where available, low-dose benzbromarone may warrant stronger consideration in gout with renal uric acid underexcretion, researchers say.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 13, 2022 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
FDA Approves Combination Pegloticase and Methotrexate for Gout FDA Approves Combination Pegloticase and Methotrexate for Gout
Pegloticase plus methotrexate has been approved as a treatment for refractory gout.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 12, 2022 Category: Drugs & Pharmacology Tags: Rheumatology News Alert Source Type: news
FDA Approves Krystexxa (pegloticase) Injection Co-Administered With Methotrexate, Expanding the Labeling to Help More People with Uncontrolled Gout Achieve a Complete Response to Therapy
Approval based on MIRROR randomized controlled trial, which showed significant improvement and sustained patient response to Krystexxa with methotrexate compared to Krystexxa alone
Trial data showed a greater than 30 percentage-point increase in... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 8, 2022 Category: Drugs & Pharmacology Source Type: news
Urate-Lowering Treatments Compared for Gout
THURSDAY, July 7, 2022 -- For relatively young and healthy patients with gout caused by renal underexcretion of uric acid, low-dose benzbromarone (LDBen) has a greater urate-lowering effect than low-dose febuxostat (LDFeb), according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 7, 2022 Category: Pharmaceuticals Source Type: news
Alcohol Consumption Habits Can Predict Gout Tophi Alcohol Consumption Habits Can Predict Gout Tophi
Drinking frequently, drinking for at least 10 years, and drinking spirits were significantly associated with tophi development, a study finds.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 28, 2022 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Methotrexate Enhances Pegloticase Response in Uncontrolled Gout Methotrexate Enhances Pegloticase Response in Uncontrolled Gout
Greater efficacy and fewer infusion reactions were seen with methotrexate-pegloticase combination than pegloticase alone in the placebo-controlled MIRROR trial.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 7, 2022 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
Gout Flares After Treat-to-Target and Tight-Control Therapy Gout Flares After Treat-to-Target and Tight-Control Therapy
How frequent are gout flares during the first and second year of a treat-to-target strategy?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 7, 2022 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Gout App Improves Treat to Target, Reduces Flares Gout App Improves Treat to Target, Reduces Flares
A smartphone app to help patients communicate their urate levels to clinicians means more achieve treatment targets and experience fewer flares.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - May 27, 2022 Category: Primary Care Tags: Rheumatology News Source Type: news
Gout Drug May Cut Mortality in Heart Failure Hospitalizations
WEDNESDAY, May 25, 2022 -- Among patients with an acute heart failure exacerbation, treatment with colchicine for a gout flare is associated with significantly lower in-hospital mortality, according to a study published online April 28 in Clinical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 25, 2022 Category: Pharmaceuticals Source Type: news
Is Gout Protective Against Dementia?
(MedPage Today) -- People with gout appeared less likely to develop dementia than age- and sex-matched peers, a database study from Korea found.
The analysis of more than 5,000 gout patients and 25,000 controls in Korea's national healthcare system... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - May 25, 2022 Category: Psychiatry Source Type: news
Gout Medicine Colchicine May Also Help Fight Heart Failure
MONDAY, May 23, 2022 -- The anti-inflammatory benefits of a common gout medicine may help save the lives of heart failure patients, researchers say.
The medication, colchicine, could also reduce the risk of heart attack and stroke in patients whose... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 23, 2022 Category: General Medicine Source Type: news
Gout Medicine May Also Help Fight Heart Failure
Title: Gout Medicine May Also Help Fight Heart FailureCategory: Health NewsCreated: 5/23/2022 12:00:00 AMLast Editorial Review: 5/23/2022 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - May 23, 2022 Category: Cardiology Source Type: news
